DD274215A5 - Verfahren zur herstellung von neuen benzimidazol-derivaten - Google Patents
Verfahren zur herstellung von neuen benzimidazol-derivaten Download PDFInfo
- Publication number
- DD274215A5 DD274215A5 DD88319141A DD31914188A DD274215A5 DD 274215 A5 DD274215 A5 DD 274215A5 DD 88319141 A DD88319141 A DD 88319141A DD 31914188 A DD31914188 A DD 31914188A DD 274215 A5 DD274215 A5 DD 274215A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- ethyl
- dihydro
- acid
- concentrated
- thienyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873728695 DE3728695A1 (de) | 1987-08-25 | 1987-08-25 | Neue benzimidazol-derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
DD274215A5 true DD274215A5 (de) | 1989-12-13 |
Family
ID=6334659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD88319141A DD274215A5 (de) | 1987-08-25 | 1988-08-23 | Verfahren zur herstellung von neuen benzimidazol-derivaten |
Country Status (17)
Country | Link |
---|---|
US (1) | US4925854A (ja) |
EP (1) | EP0304789B1 (ja) |
JP (1) | JP2818170B2 (ja) |
AT (1) | ATE86982T1 (ja) |
AU (1) | AU615939B2 (ja) |
CA (1) | CA1330440C (ja) |
DD (1) | DD274215A5 (ja) |
DE (2) | DE3728695A1 (ja) |
DK (1) | DK169701B1 (ja) |
ES (1) | ES2054752T3 (ja) |
FI (1) | FI99013C (ja) |
HU (1) | HU201746B (ja) |
IE (1) | IE63283B1 (ja) |
IL (1) | IL87561A (ja) |
NO (1) | NO170852C (ja) |
PT (1) | PT88326B (ja) |
ZA (1) | ZA886336B (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE914003A1 (en) * | 1990-11-20 | 1992-05-20 | Astra Pharma Prod | Biologically Active Amines |
US5371102A (en) * | 1992-03-11 | 1994-12-06 | University Of Hawaii | Compositions and methods of inhibiting thyroid activity |
IL113472A0 (en) | 1994-04-29 | 1995-07-31 | Lilly Co Eli | Non-peptidyl tachykinin receptor antogonists |
US5565454A (en) * | 1995-05-31 | 1996-10-15 | Ergo Science, Incorporated | Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions |
TW356468B (en) * | 1995-09-15 | 1999-04-21 | Astra Pharma Prod | Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same |
GB9526511D0 (en) * | 1995-12-23 | 1996-02-28 | Astra Pharma Prod | Pharmaceutically active compounds |
US6974815B2 (en) * | 2002-10-11 | 2005-12-13 | Bristol-Myers Squibb Company | Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents |
US9522111B2 (en) | 2011-12-16 | 2016-12-20 | Colgate-Palmolive Company | Color changing compositions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3813409A (en) * | 1972-07-31 | 1974-05-28 | Squibb & Sons Inc | Benzimidazolinone compounds |
DE3042481A1 (de) * | 1980-11-11 | 1982-06-16 | A. Nattermann & Cie GmbH, 5000 Köln | (omega)-(2-oxo-benzazolinyl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
US4367337A (en) * | 1981-01-05 | 1983-01-04 | The Sherwin-Williams Company | Process for conversion of benzimidazolones to benzotriazoles |
US4958026A (en) * | 1984-08-15 | 1990-09-18 | Schering Aktiengesllschaft | Novel dopamine derivatives, processes for their preparation, and their use as medicinal agents |
US4554287A (en) * | 1984-09-12 | 1985-11-19 | Smithkline Beckman Corporation | Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones |
-
1987
- 1987-08-25 DE DE19873728695 patent/DE3728695A1/de not_active Withdrawn
-
1988
- 1988-08-17 ES ES88113339T patent/ES2054752T3/es not_active Expired - Lifetime
- 1988-08-17 EP EP88113339A patent/EP0304789B1/de not_active Expired - Lifetime
- 1988-08-17 DE DE8888113339T patent/DE3879322D1/de not_active Expired - Lifetime
- 1988-08-17 AT AT88113339T patent/ATE86982T1/de active
- 1988-08-22 IE IE255288A patent/IE63283B1/en not_active IP Right Cessation
- 1988-08-23 DD DD88319141A patent/DD274215A5/de not_active IP Right Cessation
- 1988-08-23 JP JP63207486A patent/JP2818170B2/ja not_active Expired - Lifetime
- 1988-08-24 CA CA000575617A patent/CA1330440C/en not_active Expired - Fee Related
- 1988-08-24 HU HU884447A patent/HU201746B/hu not_active IP Right Cessation
- 1988-08-24 PT PT88326A patent/PT88326B/pt not_active IP Right Cessation
- 1988-08-24 NO NO883776A patent/NO170852C/no unknown
- 1988-08-25 IL IL87561A patent/IL87561A/xx not_active IP Right Cessation
- 1988-08-25 FI FI883930A patent/FI99013C/fi not_active IP Right Cessation
- 1988-08-25 ZA ZA886336A patent/ZA886336B/xx unknown
- 1988-08-25 AU AU21498/88A patent/AU615939B2/en not_active Ceased
- 1988-08-25 DK DK474288A patent/DK169701B1/da not_active IP Right Cessation
- 1988-08-25 US US07/236,383 patent/US4925854A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK474288D0 (da) | 1988-08-25 |
HUT49589A (en) | 1989-10-30 |
US4925854A (en) | 1990-05-15 |
NO883776L (no) | 1989-02-27 |
EP0304789A2 (de) | 1989-03-01 |
IE63283B1 (en) | 1995-04-05 |
AU615939B2 (en) | 1991-10-17 |
NO170852C (no) | 1992-12-16 |
AU2149888A (en) | 1989-03-02 |
DK169701B1 (da) | 1995-01-16 |
JP2818170B2 (ja) | 1998-10-30 |
HU201746B (en) | 1990-12-28 |
ATE86982T1 (de) | 1993-04-15 |
NO170852B (no) | 1992-09-07 |
FI883930A (fi) | 1989-02-26 |
CA1330440C (en) | 1994-06-28 |
FI99013B (fi) | 1997-06-13 |
EP0304789B1 (de) | 1993-03-17 |
IL87561A0 (en) | 1989-01-31 |
ZA886336B (en) | 1989-04-26 |
ES2054752T3 (es) | 1994-08-16 |
IL87561A (en) | 1993-02-21 |
DK474288A (da) | 1989-02-26 |
IE882552L (en) | 1989-02-25 |
FI883930A0 (fi) | 1988-08-25 |
DE3879322D1 (de) | 1993-04-22 |
JPS6468359A (en) | 1989-03-14 |
EP0304789A3 (en) | 1989-10-04 |
DE3728695A1 (de) | 1989-03-09 |
FI99013C (fi) | 1997-09-25 |
PT88326A (pt) | 1989-06-30 |
PT88326B (pt) | 1995-03-31 |
NO883776D0 (no) | 1988-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0269968A2 (de) | Heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
EP0121753A2 (de) | 1-(1,3-Dioxolan-2-ylmethyl)-azole, ihre Salze, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen | |
DD274215A5 (de) | Verfahren zur herstellung von neuen benzimidazol-derivaten | |
DE1620449B2 (de) | Substituierte benzimidazole und verfahren zu ihrer herstellung | |
CH631970A5 (de) | Verfahren zur herstellung neuer substituierter 2-phenylamino-imidazoline-(2) und deren saeureadditionssalze. | |
CH617701A5 (ja) | ||
DE2248477A1 (de) | Imidazolinverbindungen | |
DE2723464A1 (de) | Aryltrifluoraethylamine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
CH628346A5 (de) | Verfahren zur herstellung neuer xanthinderivate. | |
EP0173933A1 (de) | 1,6-Naphthyridin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
CH633288A5 (de) | Verfahren zur herstellung von neuen heterocyclylaminoderivaten. | |
DE2314114A1 (de) | Neue thiazolcarbonsaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen | |
EP0427827B1 (de) | 8-alpha-ACYLAMINO-ERGOLINE, IHRE HERSTELLUNG UND VERWENDUNG ALS ARZNEIMITTEL | |
DE2300018C2 (de) | 1-[N-Methyl-N-(β-phenyläthyl)-3-aminopropyl]- benzimidazol-Abkömmlinge | |
DE2521709A1 (de) | Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten | |
DE2417063C2 (de) | Tricyclische Sulfoximid-Derivate | |
DE3406414A1 (de) | Substituierte n-(w-(lh-imidazol-l-yl)-alkyl)-amide | |
DE2331721A1 (de) | Verfahren zur herstellung neuer heterocyclischer verbindungen | |
EP0873315B1 (de) | Phenanthridinderivate, verfahren zu ihrer herstellung und arzneimittel, enthaltend phenanthridinderivate | |
DE3519735A1 (de) | Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
EP1114037B1 (de) | Benzoxazin- und benzothiazin-derivate und deren verwendung in arzneimitteln | |
DE3531504A1 (de) | 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel | |
CH626870A5 (ja) | ||
EP0189870A1 (de) | 5-Alkoxy-pyrido [4,3-d] pyrimidine Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
DE2438965A1 (de) | Basisch substituierte 3,4-dihydro2h-isochinolin-1-thione und verfahren zu ihrer herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
VZ | Disclaimer of patent (art. 11 and 12 extension act) |